title: The "gray market" raises concerns about cost, safety, and ethics.
authors.forename: Eric T
authors.initials: ET
authors.lastname: Rosenthal
mesh_terms: D000329:Advertising / Q000379:methods / Q000639:trends; D000970:Antineoplastic Agents / Q000191:economics* / Q000600:supply & distribution*; D016527:Drug Costs / Q000941:ethics / Q000331:legislation & jurisprudence / Q000639:trends; D004992:Ethics, Medical; D006801:Humans; D007880:Legislation, Drug / Q000639:trends*; D061214:Patient Safety; D011057:Politics; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents